Jeff Bezos Backed Grail: Early Bet or Costly Call?
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Methods for cost control focus on rigorous allocation and review cycles, enabling proactive adjustments to keep spending in check.
23,014 articlesWhen a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
President Trump orders a tight 24-day sprint for Senate approval of the CLARITY Act, aiming to restore U.S. leadershi...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Strategy's Phong Le anchors the firm's crypto stance to a debt-risk threshold at $8K–$10K, underscoring balance-sheet...
Oklo has shed 28% over the past month as investors rotate away from pre-revenue nuclear developers. Utilities remain ...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
Berkshire Hathaway slashed its Amazon holding by 77% in the fourth quarter, leaving a lean position and sparking rene...
Fresh Epstein files are prompting urgent questions about governance and accountability as executives connected to the...
When a big shareholder starts selling, the market pays attention. This article explains what this major investor dump...
President Trump signals possible limited military action against Iran as nuclear talks proceed, a move that could res...